J. Whysner et al., PHENOBARBITAL MECHANISTIC DATA AND RISK ASSESSMENT - ENZYME-INDUCTION, ENHANCED CELL-PROLIFERATION, AND TUMOR PROMOTION, Pharmacology & therapeutics, 71(1-2), 1996, pp. 153-191
Chronic exposure to high doses of phenobarbital (PB) causes hepatocell
ular adenomas in both mice and rats and hepatocellular carcinomas in s
ome strains of mice, Long term PB therapy has not been found to cause
human tumors, PB is not DNA reactive, and most genotoxicity tests have
yielded negative results, PB has been extensively studied as an epige
netic, rodent liver tumor promoter, At exposures causing rodent liver
tumors, PB has measurable effects on hepatocytes: PB inhibits cell-to-
cell communication; PB induces enzymes, including P450 cytochromes; PB
stimulates proliferation and inhibits apoptosis of hepatocytes in neo
plastic foci, Threshold exposures for some of these endpoints coincide
with the threshold exposure for tumorigenesis.